Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Swiss green light for stem cell research

This article was originally published in Clinica

Executive Summary

The Swiss upper house of parliament, the Bundesrat, has passed a law allowing the use of stem cells harvested from surplus embryos (that have been produced in vitro for via artificial insemination) to be used for research purposes. The law will enter into force on March 1. Some 66% of voters in a public referendum on the subject last November (see Clinica 1136, p 2) said they would be favourable to such a law, which they considered would bring nearer the possibility of cures for diabetes, Alzheimer's and other diseases.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts